IP Library Granted Patent US 8,338,135
Granted Patent B2
US 8,338,135 · App. 13/309,594 · Granted Dec 25, 2012

High affinity human antibodies to human IL-4 receptor

Assignee: Regeneron Pharmaceuticals, inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,338,135
App. No.
13/309,594
Granted
Dec 25, 2012
Kind
B2
Abstract

An isolated human antibody or antigen binding fragment thereof which binds to human interleukin-4 receptor alpha (hIL-4Rα) with an affinity constant (K D ) of less than 200 pM, as measured by surface plasmon resonance, is provided.

Claims (12)

1. An isolated nucleic acid molecule encoding an antibody or antigen-binding fragment thereof, which specifically binds human interleukin-4 receptor comprising SEQ ID NO:1, wherein the antibody or antigen-binding fragment comprises a heavy chain variable region (HCVR) comprising three heavy chain CDRs (HCDR1, HCDR2 and HCDR3) from SEQ ID NO:581, and a light chain variable region (LCVR) comprising three light chain CDRs (LCDR1, LCDR2 and LCDR3) from SEQ ID NO:417.

2. The nucleic acid molecule of claim 1 , wherein the HCVR comprises SEQ ID NO:581.

3. The nucleic acid molecule of claim 2 , wherein the HCVR is encoded by a nucleotide sequence comprising SEQ ID NO:580.

4. The nucleic acid molecule of claim 1 , wherein the LCVR comprises SEQ ID NO:417.

5. The nucleic acid molecule of claim 4 , wherein the LCVR is encoded by a nucleotide sequence comprising SEQ ID NO:416.

6. The nucleic acid molecule of claim 1 , wherein the HCVR comprises SEQ ID NO:581 and the LCVR comprises SEQ ID NO:417.

7. The nucleic acid molecule of claim 6 , wherein the HCVR is encoded by a nucleotide sequence comprising SEQ ID NO:580 and the LCVR is encoded by a nucleotide sequence comprising SEQ ID NO:416.

8. An expression vector comprising the nucleic acid molecule of claim 1 .

9. An isolated host cell comprising the expression vector of claim 8 .

10. The host cell of claim 9 , wherein the host cell is a mammalian cell or a bacterial cell.

11. The host cell of claim 10 , wherein the host cell is a CHO cell or an E. coli.

12. A method of producing an anti-human interleukin-4 receptor antibody or antigen-binding fragment thereof, comprising growing the host cell of claim 9 under conditions permitting production of the antibody or fragment, and recovering the antibody or fragment so produced.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2014
From: STEVENS, SEAN; HUANG, TAMMY T.; MARTIN, JOEL H.; FAIRHURST, JEANETTE L.; MIKULKA, WARREN R.; POBURSKY, KEVIN J.; AHRENS, DIANA M.; WINDSOR, JOAN A.; RAFIQUE, ASHIQUE; SHI, ERGANG; PAPADOPOULOS, NICHOLAS J.; TORRES, MARCELA; LEIDICH, RAYMOND W
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 033479/0919 →
Continuity (6)
Continuation 12821499 · Jun 23, 2010
Division 12554029 · Sep 4, 2009
Division 11906517 · Oct 2, 2007
Provisional Application 60957738 · Aug 24, 2007
Provisional Application 60848694 · Oct 2, 2006
Related Publication 20120135010A1 · May 31, 2012